The effect of reduction of residual urine for reduction of bladder cancer in patients with BPH

The effect of reduction of residual urine for reduction of bladder cancer in patients with BPH - The effect of reduction of residual urine for reduction of bladder cancer in patients with BPH

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047334

Enrollment

200

Registered

2022-04-01

Start date

2022-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

drug no drug

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: *NMIBC and BPH *Bladder cancer is diagnosed by cystoscopy or radiological findings. *BPH is diagnosed by prostate size (>20mL) and IPSS (>7).

Exclusion criteria

Exclusion criteria: Bladder cancer with MIBC and/or distant metastasis was excluded in the present study.

Design outcomes

Primary

Measure	Time frame
the association between the bladder cancer recurrence and the reduction of the residual urine volume	—

Countries

Japan

Contacts

Public ContactNobuhiro Haga

Fukuoka University, Faculty of Medicine Department of Urology

urology@fukuoka-u.ac.jp0928011011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026